Literature DB >> 14652521

Comprehensive geriatric assessment.

Darryl Wieland1, Victor Hirth.   

Abstract

BACKGROUND: As an adjunct to the general and cancer-specific clinical and diagnostic examinations, comprehensive geriatric assessment (CGA) is an integral tool that examines factors affecting the course of disease and the outcome of treatment. The principal areas of focus of the CGA include the patient's functional, physical, mental, emotional, pharmacotherapeutic, and socioeconomic status.
METHODS: We describe the role of CGA in the identification and management of frail elderly patients. The literature is reviewed to outline the components, programmatic configurations, and process of CGA. Information from systematic reviews of clinical trials of different CGA program models is summarized, and observations relating to the research agenda concerning the applicability of CGA and CGA principles to management of older cancer patients are discussed.
RESULTS: Since age itself is not predictive of outcome in an elderly cancer patient, the CGA helps to distinguish between elderly patients who should be treated with intent to cure and those who will benefit from clinical oncologic and geriatric co-management.
CONCLUSIONS: A more accurate evaluation of prognostic indicators that includes CGA parameters could lead to a higher number of older patients being included in clinical cancer trials and being treated effectively in practice. It would also identify those who would benefit from gero-oncologic CGA and ongoing management aimed at maintaining function and community living.

Entities:  

Mesh:

Year:  2003        PMID: 14652521     DOI: 10.1177/107327480301000603

Source DB:  PubMed          Journal:  Cancer Control        ISSN: 1073-2748            Impact factor:   3.302


  21 in total

1.  Letter to the editor: "Phase II trial of S-1 monotherapy in elderly or frail patients with metastatic colorectal cancer".

Authors:  M J Molina-Garrido; Carmen Guillén-Ponce
Journal:  Invest New Drugs       Date:  2010-12-16       Impact factor: 3.850

2.  Translation Requires Evidence: Does Cancer-Specific CGA Lead to Better Care and Outcomes?

Authors:  Kerri M Clough-Gorr; Rebecca A Silliman
Journal:  Oncology (Williston Park)       Date:  2008       Impact factor: 2.990

3.  Assessment of health status in elderly patients with cancer.

Authors:  Joanna Kaźmierska
Journal:  Rep Pract Oncol Radiother       Date:  2012-08-09

Review 4.  Interventions to prevent disability in frail community-dwelling older persons: an overview.

Authors:  Ramon Daniels; Silke Metzelthin; Erik van Rossum; Luc de Witte; Wim van den Heuvel
Journal:  Eur J Ageing       Date:  2010-02-09

5.  The eight-item modified Medical Outcomes Study Social Support Survey: psychometric evaluation showed excellent performance.

Authors:  André Moser; Andreas E Stuck; Rebecca A Silliman; Patricia A Ganz; Kerri M Clough-Gorr
Journal:  J Clin Epidemiol       Date:  2012-07-20       Impact factor: 6.437

Review 6.  Treatment of colorectal cancer in the elderly.

Authors:  Monica Millan; Sandra Merino; Aleidis Caro; Francesc Feliu; Jordi Escuder; Tani Francesch
Journal:  World J Gastrointest Oncol       Date:  2015-10-15

7.  Examining five- and ten-year survival in older women with breast cancer using cancer-specific geriatric assessment.

Authors:  Kerri M Clough-Gorr; Soe Soe Thwin; Andreas E Stuck; Rebecca A Silliman
Journal:  Eur J Cancer       Date:  2011-07-07       Impact factor: 9.162

8.  Older breast cancer survivors: geriatric assessment domains are associated with poor tolerance of treatment adverse effects and predict mortality over 7 years of follow-up.

Authors:  Kerri M Clough-Gorr; Andreas E Stuck; Soe Soe Thwin; Rebecca A Silliman
Journal:  J Clin Oncol       Date:  2009-12-14       Impact factor: 44.544

Review 9.  Treatment of Rectal Cancer in Older Adults.

Authors:  Ayesha R Sheikh; Hassan Yameen; Kevan Hartshorn
Journal:  Curr Oncol Rep       Date:  2018-11-20       Impact factor: 5.075

10.  The reduction of disability in community-dwelling frail older people: design of a two-arm cluster randomized controlled trial.

Authors:  Silke F Metzelthin; Erik van Rossum; Luc P de Witte; Marike R C Hendriks; Gertrudis I J M Kempen
Journal:  BMC Public Health       Date:  2010-08-23       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.